US Orders 300 Million Doses of Coronavirus Vaccine


The U.S. government has ordered 300 million doses of a COVID-19 vaccine in development by AstraZeneca and Oxford University and hopes to have the vaccine available as early as October.

“This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,” Department of Health and Human Services Secretary Alex Azar said in a Thursday statement.

“Getting a vaccine to the American public as soon as possible is one part of President Trump’s multi-faceted strategy for safely reopening our country and bringing life back to normal, which is essential to Americans’ physical and mental well-being in so many ways.”

Operation Warp Speed is President Donald Trump’s initiative to develop a COVID-19 vaccine by the end of the year.

“The Trump Administration is making multiple major investments in developing and manufacturing promising vaccines long before they’re approved so that a successful vaccine will reach the American people without a day wasted,” Azar said.

Costco Customers Enraged After Chain Offers New Deal Americans Can't Have, Rivaling $1.50 Hot Dog

AstraZeneca said that it has received over $1 billion from the U.S. Biomedical Advanced Research and Development Authority to develop the vaccine, the Los Angeles Times reported.

Although just one of many vaccines in production, the Oxford prototype has been one of the quickest to develop with human testing starting in late April.

The vaccine — named AZD1222 — injects the coronavirus’ genetic material into a neutralized cold virus and triggers the immune system to fight it off by mimicking COVID-19.

Preliminary test results might not be available until mid-June and then more extensive tests will bein.

Are you hopeful about the likelihood of getting a vaccine for the coronavirus before the end of the year?

“We are so proud to be collaborating with Oxford University to turn their groundbreaking work into a medicine that can be produced on a global scale,” AstraZeneca chief executive Pascal Soriot said in a statement.

AstraZeneca also received $80 million from the British government on Sunday to “make up to up to 30 million doses available by September for people in the U.K,” according to the Times.

The company said it is now working with international organizations such as the World Health Organization “for the fair allocation and distribution of the vaccine all around the world.”

“Several more agreements are expected to deliver AstraZeneca’s commitment to ensure global access,” a representative told Fortune in an email.

“These agreements are happening in parallel in order to ensure broad and equitable supply of the vaccine throughout the world at no profit during the pandemic.”

Watch: Furious Democrats Ask Capitol Police to Kick Woman Out of Fauci Hearing - 'Take Your Starbucks with You!'

The United States has also provided $30 million to French pharmaceutical giant Sanofi to develop a COVID-19 vaccine.

“The U.S. government has the right to the largest pre-order because it’s invested in taking the risk,” Sanofi CEO Paul Hudson told Bloomberg News.

He later added, “That’s how it will be because they’ve invested to try and protect their population, to restart their economy.”

Truth and Accuracy

Submit a Correction →

We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

, , , , , ,
Erin Coates was an editor for The Western Journal for over two years before becoming a news writer. A University of Oregon graduate, Erin has conducted research in data journalism and contributed to various publications as a writer and editor.
Erin Coates was an editor for The Western Journal for over two years before becoming a news writer. She grew up in San Diego, California, proceeding to attend the University of Oregon and graduate with honors holding a degree in journalism. During her time in Oregon, Erin was an associate editor for Ethos Magazine and a freelance writer for Eugene Magazine. She has conducted research in data journalism, which has been published in the book “Data Journalism: Past, Present and Future.” Erin is an avid runner with a heart for encouraging young girls and has served as a coach for the organization Girls on the Run. As a writer and editor, Erin strives to promote social dialogue and tell the story of those around her.
Tucson, Arizona
Graduated with Honors
Bachelor of Arts in Journalism, University of Oregon
Books Written
Contributor for Data Journalism: Past, Present and Future
Prescott, Arizona
Languages Spoken
English, French
Topics of Expertise
Politics, Health, Entertainment, Faith